CP-944629

• Description:

  CP-944629 (Compound 20) is an inhibitor of p38 alpha kinase with an IC50 of 3.2. CP-944629 can be studied in research for chronic inflammation diseases[1].

• UNSPSC:

  12352005

• Target:

  P38 MAPK

• Related Pathways:

  MAPK/ERK Pathway

• Field of Research:

  Inflammation/Immunology

• Smiles:

  FC1=C(C=C(C(C2=C(OC=N2)C3=CN4C(C=C3)=NN=C4C(C)(C)C)=C1)F)F

• Molecular Formula:

  C19H15F3N4O

• Molecular Weight:

  372.34

• References & Citations:

  [1]Shashi Nayana, M. R., et al., (2008) . CoMFA and docking studies on triazolopyridine oxazole derivatives as p38 MAP kinase inhibitors. European journal of medicinal chemistry, 43 (6), 1261–1269.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [668990-94-1]